Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 142

1.

Hyperthermia generated with ferucarbotran (Resovist®) in an alternating magnetic field enhances cisplatin-induced apoptosis of cultured human oral cancer cells.

Sato I, Umemura M, Mitsudo K, Kioi M, Nakashima H, Iwai T, Feng X, Oda K, Miyajima A, Makino A, Iwai M, Fujita T, Yokoyama U, Okumura S, Sato M, Eguchi H, Tohnai I, Ishikawa Y.

J Physiol Sci. 2014 May;64(3):177-83. doi: 10.1007/s12576-014-0309-8. Epub 2014 Mar 12.

PMID:
24619404
2.

Hyperthermia treatment of tumors by mesenchymal stem cell-delivered superparamagnetic iron oxide nanoparticles.

Kalber TL, Ordidge KL, Southern P, Loebinger MR, Kyrtatos PG, Pankhurst QA, Lythgoe MF, Janes SM.

Int J Nanomedicine. 2016 May 9;11:1973-83. doi: 10.2147/IJN.S94255. eCollection 2016.

3.

The intratumoral administration of ferucarbotran conjugated with doxorubicin improved therapeutic effect by magnetic hyperthermia combined with pharmacotherapy in a hepatocellular carcinoma model.

Jeon MJ, Ahn CH, Kim H, Chung IJ, Jung S, Kim YH, Youn H, Chung JW, Kim YI.

J Exp Clin Cancer Res. 2014 Jul 18;33:57. doi: 10.1186/s13046-014-0057-x.

4.

IFN-gamma down-regulates Hsp27 and enhances hyperthermia-induced tumor cell death in vitro and tumor suppression in vivo.

Oba M, Yano S, Shuto T, Suico MA, Eguma A, Kai H.

Int J Oncol. 2008 Jun;32(6):1317-24.

PMID:
18497994
5.

Simulation and experimental studies on magnetic hyperthermia with use of superparamagnetic iron oxide nanoparticles.

Murase K, Oonoki J, Takata H, Song R, Angraini A, Ausanai P, Matsushita T.

Radiol Phys Technol. 2011 Jul;4(2):194-202. doi: 10.1007/s12194-011-0123-4. Epub 2011 Jun 11.

PMID:
21667079
6.

STI-571 (Gleevec) potentiates the effect of cisplatin in inhibiting the proliferation of head and neck squamous cell carcinoma in vitro.

Wang-Rodriguez J, Lopez JP, Altuna X, Chu TS, Weisman RA, Ongkeko WM.

Laryngoscope. 2006 Aug;116(8):1409-16.

PMID:
16885745
7.

Combined arsenic trioxide-cisplatin treatment enhances apoptosis in oral squamous cell carcinoma cells.

Nakaoka T, Ota A, Ono T, Karnan S, Konishi H, Furuhashi A, Ohmura Y, Yamada Y, Hosokawa Y, Kazaoka Y.

Cell Oncol (Dordr). 2014 Apr;37(2):119-29. doi: 10.1007/s13402-014-0167-7. Epub 2014 Mar 6.

PMID:
24599717
8.

Usefulness of combined treatment with mild temperature hyperthermia and/or tirapazamine in the treatment of solid tumors: its independence of p53 status.

Masunaga S, Ono K, Takahashi A, Ohnishi K, Ohnishi T, Suzuki M, Nagata K, Kinashi Y, Nagasawa H, Uto Y, Hori H.

Cancer Sci. 2003 Jan;94(1):125-33.

9.

Contribution of a 300 kHz alternating magnetic field on magnetic hyperthermia treatment of HepG2 cells.

Wang X, Chen Y, Huang C, Wang X, Zhao L, Zhang X, Tang J.

Bioelectromagnetics. 2013 Feb;34(2):95-103. doi: 10.1002/bem.21761. Epub 2012 Oct 11.

PMID:
23059525
10.

Dual pH and temperature stimuli-responsive magnetic nanohydrogels for thermo-chemotherapy.

Jaiswal MK, Pradhan A, Banerjee R, Bahadur D.

J Nanosci Nanotechnol. 2014 Jun;14(6):4082-9.

PMID:
24738355
11.

Enhancement of cell killing by induction of apoptosis after treatment with mild hyperthermia at 42 degrees C and cisplatin.

Ohtsubo T, Igawa H, Saito T, Matsumoto H, Park H, Song CW, Kano E, Saito H.

Radiat Res. 2001 Jul;156(1):103-9.

PMID:
11418078
12.

Anticancer effect and feasibility study of hyperthermia treatment of pancreatic cancer using magnetic nanoparticles.

Wang L, Dong J, Ouyang W, Wang X, Tang J.

Oncol Rep. 2012 Mar;27(3):719-26. doi: 10.3892/or.2011.1567. Epub 2011 Nov 30.

PMID:
22134718
13.

Synergistic antitumor effect of AAV-mediated TRAIL expression combined with cisplatin on head and neck squamous cell carcinoma.

Jiang M, Liu Z, Xiang Y, Ma H, Liu S, Liu Y, Zheng D.

BMC Cancer. 2011 Feb 3;11:54. doi: 10.1186/1471-2407-11-54.

14.

Magnetic stent hyperthermia for esophageal cancer: an in vitro investigation in the ECA-109 cell line.

Liu JY, Zhao LY, Wang YY, Li DY, Tao D, Li LY, Tang JT.

Oncol Rep. 2012 Mar;27(3):791-7. doi: 10.3892/or.2011.1603. Epub 2011 Dec 21.

PMID:
22200741
15.

Intraoperative hyperthermic chemotherapy perfusion for malignant pleural mesothelioma: an in vitro evaluation.

Cameron RB, Hou D.

J Thorac Cardiovasc Surg. 2013 Feb;145(2):496-504. doi: 10.1016/j.jtcvs.2012.10.042. Epub 2012 Nov 20.

16.
17.

Magnetic nanoparticle hyperthermia enhancement of cisplatin chemotherapy cancer treatment.

Petryk AA, Giustini AJ, Gottesman RE, Kaufman PA, Hoopes PJ.

Int J Hyperthermia. 2013 Dec;29(8):845-51. doi: 10.3109/02656736.2013.825014. Epub 2013 Oct 21.

18.

Cisplatin, hyperthermia, and radiation (trimodal therapy) in patients with locally advanced head and neck tumors: a phase I-II study.

Amichetti M, Graiff C, Fellin G, Pani G, Bolner A, Maluta S, Valdagni R.

Int J Radiat Oncol Biol Phys. 1993 Aug 1;26(5):801-7.

PMID:
8344849
19.

Alternating magnetic field-induced hyperthermia increases iron oxide nanoparticle cell association/uptake and flux in blood-brain barrier models.

Dan M, Bae Y, Pittman TA, Yokel RA.

Pharm Res. 2015 May;32(5):1615-25. doi: 10.1007/s11095-014-1561-6. Epub 2014 Nov 7.

20.

Thermosensitization and induction of apoptosis or cell-cycle arrest via the MAPK cascade by parthenolide, an NF-╬║B inhibitor, in human prostate cancer androgen-independent cell lines.

Hayashi S, Koshiba K, Hatashita M, Sato T, Jujo Y, Suzuki R, Tanaka Y, Shioura H.

Int J Mol Med. 2011 Dec;28(6):1033-42. doi: 10.3892/ijmm.2011.760. Epub 2011 Jul 29.

PMID:
21805026

Supplemental Content

Support Center